• Home
  • Terms of Use
  • Privacy Policy
  • Disclosure
Saturday, June 25, 2022
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
  • Home
  • News
  • Business
  • Technology
    • Crytpocurrency
    • Gaming
    • Gadgets
  • Sports
  • Health
  • General
    • Business Services
  • Travel
  • Press Releases
  • Videos
No Result
View All Result
Omicron b11529 Variant
No Result
View All Result
Home Covid-19

WHO Regional Office For The Eastern Mediterranean Concludes COVID-19 Response Review Mission To Sudan, With Actionable Recommendations Across Nine Pillars – Sudan – ReliefWeb

by NewsReporter
June 22, 2022
in Covid-19
Reading Time: 2 mins read
Share on FacebookShare on Twitter

Cairo, 22 June 2022 – A 10-strong team of multidisciplinary experts from the World Health Organization (WHO) Regional Office for the Eastern Mediterranean has just returned from a mission to Sudan, where they reviewed the country’s response to COVID-19 and other health emergencies. Leading the six-day mission were Regional Emergency Director Dr Richard Brennan, and WHO Representative in Sudan Dr Ni’ma Saeed Abid, who worked closely with acting Federal Minister of Health, Dr Haytham Awad, and Khartoum State Ministry of Health Director-General, Dr Mahmoud Al-Gayem, as well as UN partners – particularly UNICEF – and local nongovernmental organizations.

“We all know that there have been a lot of missions to Sudan over the past few years. The most important results of this particular mission are actionable recommendations and a targeted plan,” said Dr Brennan, who presented the team’s preliminary findings and recommendations to the Federal Minister of Health and a large assembly of ministry officials, along with members of the Sudan WHO country office, UN partners and other stakeholders on Friday 17 June 2022.

Among the mission’s recommendations were: revising the national COVID-19 vaccination strategy – including prioritizing focus on priority groups such as health care workers, individuals with comorbidities, the elderly and refugees; ensuring adherence to the national treatment protocol for COVID-19; developing a plan to scale up access to medical oxygen; revitalizing cross-border collaboration on health security issues with neighbouring countries, beginning with Egypt; authorizing state media offices affiliated to the Ministry of Health to engage directly with the media on state-level issues; and developing a risk communication and community engagement strategy with defined roles and responsibilities at the national, state and locality levels, among others. Cutting across the nine examined pillars, however, was the elimination of overlapping authorities for enhanced coordination and streamlined future responses within the Ministry of Health.

In addition to examining Sudan’s COVID-19 response, the mission’s objectives included the facilitation of stakeholder consensus-building to identify gaps and the review of the country’s readiness to respond to other priority risks.

“We face almost the same emergencies in Sudan each year with varying degrees of severity, so we need to be more focused on preparedness,” observed Dr Abid.

The mission’s assessment mechanism included desk reviews, on-site interviews with a wide array of key informants, group discussions, bilateral talks, direct observations and field visits. The latter included primary, secondary and tertiary care centres, two testing sites, the national public health laboratory, the Ministry of Health-affiliated call centre, a private isolation facility, Khartoum International Airport, SUNA News Agency and an oxygen production site, among numerous other visits in the locality of Khartoum. While some pillars also examined other localities in Khartoum State – such as Omdurman and Jebel Al-Awlyaa – others headed out to River Nile State for a two-day review visit.

The nine examined pillars were Partnership and Coordination, Communications (external and internal), Infection Prevention and Control, Case Management and Clinical Operations, International Health Regulations and Social Measures, Risk Communication and Community Engagement, Research and Knowledge Management, Essential Health Services and Systems, and COVID-19 Vaccine.

Related Posts

covid-19:-ma-reports-52-coronavirus-cases-on-cape-cod-and-islands-–-cape-cod-times

COVID-19: MA Reports 52 Coronavirus Cases On Cape Cod And Islands – Cape Cod Times

by NewsReporter
June 25, 2022
0

According to the state Department of Public Health’s daily report on Thursday, there were 1,700 newly confirmed cases of COVID-19 in Massachusetts, for a total of 1,755,678 since the pandemic began.  There were also 134 new probable cases of coronavirus, for a total of 158,160 statewide. The DPH said that as of June 22,...

pop-up-covid-19-vaccination-clinic-offered-at-rogers-park-and-other-spots-in-danbury-–-danbury-news-times

Pop-Up COVID-19 Vaccination Clinic Offered At Rogers Park And Other Spots In Danbury – Danbury News Times

by NewsReporter
June 25, 2022
0

This is a carousel. Use Next and Previous buttons to navigate 1of3Alec Golding, program coordinator, right, and Sheila Lacouture, registered nurse, work in the Community Health Center (CHC) walk-up COVID-19 vaccine clinic in Patrick R Waldron Veterans Hall in Rogers Park. The clinic is administering the COVID-19 vaccine shots. June...

wayne-newton-tests-positive-for-covid-19,-cancels-several-las-vegas-shows-–-news3lv

Wayne Newton Tests Positive For COVID-19, Cancels Several Las Vegas Shows – News3LV

by NewsReporter
June 25, 2022
0

Wayne Newton tests positive for COVID-19, cancels several Las Vegas shows  News3LV

valneva-receives-marketing-authorization-in-europe-for-inactivated-whole-virus-covid-19-vaccine-vla2001-–-biospace

Valneva Receives Marketing Authorization In Europe For Inactivated Whole-Virus COVID-19 Vaccine VLA2001 – BioSpace

by NewsReporter
June 25, 2022
0

 VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe Saint Herblain (France), June24, 2022 – Valneva SE  (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Valneva’s inactivated whole-virus COVID-19 vaccine,...

hiv-testing-before-and-during-the-covid-19-pandemic…-–-centers-for-disease-control-and-prevention-(.gov)

HIV Testing Before And During The COVID-19 Pandemic… – Centers For Disease Control And Prevention (.gov)

by NewsReporter
June 25, 2022
0

Elizabeth A. DiNenno, PhD1; Kevin P. Delaney, PhD1; Marc A. Pitasi, MPH1; Robin MacGowan, MPH1; Gillian Miles, MPH1; Andre Dailey, MSPH1; Cari Courtenay-Quirk, PhD1; Kathy Byrd, MD1; Dominique Thomas, MPA1; John T. Brooks, MD1; Demetre Daskalakis, MD1; Nicoline Collins, MPH1 (View author affiliations) View suggested citationSummary What is already known...

age-and-sex-specific-risks-of-myocarditis-and-pericarditis-following-covid-19-messenger-rna-vaccines-–-nature.com

Age And Sex-Specific Risks Of Myocarditis And Pericarditis Following Covid-19 Messenger RNA Vaccines – Nature.com

by NewsReporter
June 25, 2022
0

AbstractCases of myocarditis and pericarditis have been reported following the receipt of Covid-19 mRNA vaccines. As vaccination campaigns are still to be extended, we aimed to provide a comprehensive assessment of the association, by vaccine and across sex and age groups. Using nationwide hospital discharge and vaccine data, we analysed...

Omicron b11529 Variant

© 2021

Navigate Site

  • Home
  • Terms of Use
  • Privacy Policy
  • Disclosure

Follow Us

No Result
View All Result
  • Home

© 2021